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Several submaximal exercise tests are reliable, valid and acceptable in peoplewith
chronic pain, ﬁbromyalgia or chronic fatigue: a systematic review
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A B S T R A C T
Question: Are submaximal and maximal exercise tests reliable, valid and acceptable in people with
chronic pain, ﬁbromyalgia and fatigue disorders? Design: Systematic review of studies of the
psychometric properties of exercise tests. Participants: People older than 18 years with chronic pain,
ﬁbromyalgia and chronic fatigue disorders. Intervention: Studies of themeasurement properties of tests
of physical capacity in peoplewith chronic pain, ﬁbromyalgia or chronic fatigue disorderswere included.
Outcome measures: Studies were required to report: reliability coefﬁcients (intraclass correlation
coefﬁcient, alpha reliability coefﬁcient, limits of agreements and Bland-Altman plots); validity
coefﬁcients (intraclass correlation coefﬁcient, Spearman’s correlation, Kendal T coefﬁcient, Pearson’s
correlation); or dropout rates. Results: Fourteen studies were eligible: none had low risk of bias, 10 had
unclear risk of bias and four had high risk of bias. The included studies evaluated: A˚strand test; modiﬁed
A˚strand test; Lean body mass-based A˚strand test; submaximal bicycle ergometer test following another
protocol other than A˚strand test; 2-kmwalk test; 5-minute, 6-minute and 10-minute walk tests; shuttle
walk test; and modiﬁed symptom-limited Bruce treadmill test. None of the studies assessed maximal
exercise tests. Where they had been tested, reliability and validity were generally high. Dropout rates
were generally acceptable. The 2-km walk test was not recommended in ﬁbromyalgia. Conclusion:
Moderate evidence was found for reliability, validity and acceptability of submaximal exercise tests in
patients with chronic pain, ﬁbromyalgia or chronic fatigue. There is no evidence about maximal exercise
tests in patients with chronic pain, ﬁbromyalgia and chronic fatigue. [Ratter J, Radlinger L, Lucas C
(2014) Several submaximal exercise tests are reliable, valid and acceptable in people with chronic
pain, ﬁbromyalgia or chronic fatigue: a systematic review. Journal of Physiotherapy 60: 144–150]
 2014 Published by Elsevier B.V. on behalf of Australian Physiotherapy Association. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Functional disorders are illnesses in which there is no obvious
pathology or anatomical change in an organ, and there is a
presumed dysfunction of an organ or system. Chronic pain,
ﬁbromyalgia and chronic fatigue disorders are often-mentioned
diagnoses belonging to functional disorders.1 Chronic pain is
deﬁned as pain that has lasted longer than 3 to 6months,2 although
some use 12 months as the threshold.3 A popular alternative
deﬁnition of chronic pain, involving no arbitrarily ﬁxed durations is
‘pain that extends beyond the expected period of healing’.2
Fibromyalgia is a chronic functional illness that presents with
widespread musculoskeletal pain, including above and below the
waist, as well as the right and left sides of the body, and the
physical ﬁnding of 11 of 18 tender points. These simple criteria
provide 85% speciﬁcity and sensitivity in differentiating patients
with ﬁbromyalgia from those with other rheumatic diseases.4
Chronic fatigue is deﬁned as persistent or relapsing fatigue lasting
more than 6 months, with more than four of the following
symptoms: impaired memory, sore throat, tender cervical or
axillary lymph nodes, muscle pain, multifocal joint pain, new
headaches, unrefreshing sleep, and post-exertion malaise.4http://dx.doi.org/10.1016/j.jphys.2014.06.011
1836-9553/ 2014 Published by Elsevier B.V. on behalf of Australian Physiotherapy A
creativecommons.org/licenses/by-nc-nd/3.0/).A challenging diagnostic dilemma with regard to the above
diagnoses is overlap of symptoms. Chronic widespread pain, the
cardinal symptom of ﬁbromyalgia, is prevalent and co-occurs with
numerous symptom-based conditions such as chronic fatigue
syndrome, joint pain and psychiatric disorders.5 Estimates of the
number of patients with ﬁbromyalgia who meet the criteria for
chronic fatigue disorders range from 30 to 70%.4 Fibromyalgia
syndrome and chronic fatigue syndrome are similar in many ways
– both conditions lack an accepted disease model that can explain
signs and symptoms in terms of speciﬁc pathophysiological
abnormalities.6
In Europe, 19% of adults experience chronic pain of moderate to
severe intensity with serious negative implications for their social
and working lives.7 Fatigue is also a common symptom in the
community, affecting from 0.007 to 2.8% in the general adult
population and from 0.006 to 3.0% in primary care.8 Fibromyalgia
syndrome affects 2 to 4% of the general population, and over 5% of
patients in general medical practice.9
Recent studies have conﬁrmed previous evidence of the
enormous indirect socioeconomic costs of chronic pain, ﬁbromy-
algia and chronic fatigue disorders. The overall ﬁnancial costs of
chronic pain to society are comparable with the costs of cancer orssociation. This is an open access article under the CC BY-NC-ND license (http://
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database searches (n = 3496)
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Studies included in the review (n = 14)
Records excluded after screening 
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• ineligible assessments (n = 32)
• no psychometric data (n = 28)
Records identified 
through other 
sources (n = 0)
Records after duplicates removed (n = 2637)
Records screened (n = 2637)
Figure 1. Flow of studies through the review.
Research 145cardiovascular diseases.10,11 Chronic pain is also associated with
many secondary stressors such as sleep disruption, unemployment
and interpersonal tensions.12 Chronic fatigue syndrome is char-
acterised by profound disabling fatigue lasting at least 6 months
and accompanied by numerous symptoms such as pain, sleep
difﬁculties and cognitive impairment.13 Chronic pain, ﬁbromyalgia
and chronic fatigue also have personal economic, psychological
and social consequences for the affected individuals.12,14,15 One in
three people with pain or fatigue disorders is unable or less able to
maintain an independent lifestyle11 and 50 to 66% of people
suffering from chronic pain are less able or unable to exercise,
enjoy normal sleep, perform household chores, attend social
activities, drive a car, walk or have sexual relations.16
Although key risk factors have been identiﬁed, the incidence of
chronic pain, ﬁbromyalgia and fatigue disorders has been
increasing, rendering their management a persistent challenge.14
Fear avoidance models emphasise psychological distress, pain-
related anxiety, anxiety sensitivity, fear of illness/injury, fear of re-
injury and catastrophising in the development andmaintenance of
disabling chronic pain.17 International and national guidelines
recommend graded activity and graded exposure in the treatment
of chronic disorders.15,18–21
The validity of self-reported assessment of pain and physical
disability is controversial. The level of pain reported by peoplewith
chronic pain is not always related to their reports of their physical
disability. Nevertheless, pain, fear of pain and its consequences are
subjective experiences and are difﬁcult to assess.22 Observational
measures may be useful to corroborate subjective reports when
evaluating each person’s capability.23,24 Ideally, evaluation of
physical function in people with chronic pain and chronic fatigue
disorders should rely on a combination of clinical assessment of
impairments, behavioural observation of physical function, and
self-report.25 Despite this, there is limited evidence about the
acceptability, reliability and validity of submaximal and maximal
exercise testsmeasuring physical ﬁtness and capacity in this group
of people. To assess aerobic capacity, maximal testing with
calorimetry is considered to be the gold standard.26,27 However,
outcomes of this measurement are strongly inﬂuenced by
motivation, fear and pain.26 Furthermore, outcomes are invalid
when fear and pain expectation rather than aerobic capacity limit
performance.28 In one study, over 90% of the variance in
performance among disabled individuals with chronic musculo-
skeletal painwas predicted bypsychosocial factors like self-efﬁcacy,
perceived emotional and physical functioning, pain intensity and
pain cognition.29 Several studies of people with chronic pain have
identiﬁed discrepancies between self-report of physical activity and
actual level of physical activity. Poorer achievement on physical
performance testingbypeoplewith lowbackpainhasbeen linked to
fear of injury during movement, depression, cognitive factors, pain
expectations, pain increase during testing, disability status and the
presence of a solicitous spouse.23
The conventional A˚strand bicycle test and maximal exercise
capacity tests tend to be unacceptable in people with a very poor
aerobic capacity30 and the validity is low in those with chronic low
back pain.27 Also, physical assessments used to detect the degree of
disability in other disease states have major limitations when
applied to people with ﬁbromyalgia and chronic fatigue syn-
drome.31
In the last decade, many submaximal tests have been developed
as an alternative tomaximal exercise testing.28 Themost commonly
used test in people with chronic low back pain is the submaximal
A˚strand bicycle test. Its test-retest reliability seems to be good in
people with chronic low back pain.32 However, submaximal testing
tends to underestimate or overestimatemaximal oxygen consump-
tion (VO2max) in 15% of healthy subjects.
33 Nevertheless, due to
pain, fatigue and fear of worsening their symptoms, people with
chronic pain, ﬁbromyalgia and fatigue disorders are often unable to
perform the submaximal A˚strand bicycle test.34,35
Guidance for clinicians in this area is needed because the
variety in attributes of the available instruments makes it difﬁcultto select the best instrument. Therefore, the research question of
this systematic review was:
In people with chronic pain, ﬁbromyalgia and fatigue disorders,
aremaximal and submaximal physical capacity tests reliable, valid
and acceptable?
Method
Identiﬁcation and selection of trials
A sensitive search was performed in PubMed, Embase, PEDro
and the Cochrane library in October 2012. The search strategy was
developed by a medical librarian specialist. The detailed strategy
for PubMed is presented in Appendix 1 (see eAddenda). Eligible
studies could use any study design that reported on one or more
measurement properties of physical capacity tests in adults with
chronic pain, chronic fatigue disorders or ﬁbromyalgia. Data were
extracted for reliability coefﬁcients, validity coefﬁcients and
dropout rates. Studies published in any language and in any year
were eligible for inclusion.
Records retrieved by the search were assessed for eligibility by
two reviewers (JR, LR) working independently, initially based on
titles and abstracts, with potentially eligible articles being assessed
in full-text to conﬁrm eligibility. Discrepancies were reviewed and
consensus was achieved by discussion. Reasons for exclusion were
given for each reference and are documented in Figure 1. For each
included study, the exercise tests assessed were tabulated along
with the psychometric tests performed and their results.
Assessment of characteristics of trials
Quality
The COSMIN 4-point rating scale (excellent, good, fair, poor)
was used to evaluate elements of the methodological quality
Ratter et al: Psychometrics of exercise tests in chronic pain patients146(measurement error, reliability, criterion validity) of the studies. A
methodological quality score for each relevant element was
obtained by taking the lowest rating of any item for that element
(‘worse score counts’).36 Two authors (JR, LR) independently
assessed the risk of bias in included studies, with consensus
achieved by discussion.
Participants
Studies involving adults (ie, aged 18 years or older)with chronic
pain, ﬁbromyalgia or chronic fatigue disorders were eligible.
Exercise tests
Studies were required to have assessed the psychometric
properties of any of the following submaximal exercise tests to be
eligible: A˚strand test; modiﬁed A˚strand test; Lean body mass-
based A˚strand test; submaximal bicycle ergometer test following a
protocol other than the A˚strand test; 2-km walk test; shuttle walk
test; modiﬁed symptom-limited Bruce treadmill test; and walking
distance over 5, 6 or 10 minutes.
Psychometric outcomes
Data were extracted, where available, for the following
reliability coefﬁcients: intra class correlation (ICC), alpha reliability
coefﬁcient, limits of agreements, and Bland-Altman plots. Data
were also extracted for the validity coefﬁcients: ICC, Spearman’s
correlation, Kendal T coefﬁcient, and Pearson’s correlation.
Dropout rates were also recorded.
Data analysis
The following data were extracted from each eligible study and
tabulated: study design, participants (sample size, age, diagnosis),
aim, exercise test, psychometric outcomes and methodological
quality. Data for individual studies were reported quantitatively
and the evidence was also summarised qualitatively. No meta-
analyses were performed because of heterogeneity among the
study designs used, heterogeneity of the psychometric properties
evaluated and incomplete reporting of the data.
The evidence was graded, based on the number of studies, their
methodological quality, and the consistency of the available
evidence into ﬁve categories: strong (consistent ﬁndings in two or
more high-quality studies); moderate (consistent ﬁndings in one
high-quality and one low-quality study, or in two or more low-
quality studies); limited (only one study); conﬂicting (inconsistent
ﬁndings); and no evidence (no studies). The authors considered
ﬁndings to be consistent if at least 75% of the available studies
reported the same conclusion37.
Results
Flow of trials through the review
The search yielded 3496 records, which amounted to 2637
potentially relevant articles after removal of duplicates. After initial
screening, 74 of these articles were obtained in full text for further
assessment. The ﬁnal selection included 14 studies involving 1275
participants. The selection procedure and the reasons for exclusion
are presented in Figure 1. Inter-rater agreement about the eligibility
of studieswas assessed byusing an unweighted Kappa. Unweighted
Kappa for the selection of abstractswas k = 0.91, unweighted Kappa
for the selection of full texts was k = 0.74; this is considered to be
excellent inter-rater agreement.
Characteristics of the included trials
Quality
The reviewers rated the included studies as being ‘fair’ or ‘poor’
on the COSMIN checklist, as presented in Appendix 2
(see eAddenda). Common methodological shortcomings wereun-blinded assessment, uncertainty about other measurement
errors and absence of gold standards.
Participants
Sample sizes in the included studies ranged from 24 to 683. The
mean age of all participants was 45 years, with mean age in the
individual studies ranging from 34 to 82 years. Age, diagnosis and
number of participants in individual studies are presented in
Table 1.
Exercise tests
The exercise tests listed above were all assessed by one study
each, except for the conventional A˚strand test (three studies), the
5-minute walk test (three studies), and a submaximal bicycle
ergometer test following a protocol other than the A˚strand test
(three studies).
Are maximal and submaximal physical capacity tests in people
with chronic pain, ﬁbromyalgia and fatigue disorders reliable,
valid and acceptable?
No data regarding maximal exercise tests in the population of
interest were identiﬁed. The data extracted from studies of
submaximal tests are presented in Table 1. The psychometric
properties of each submaximal test are summarised descriptively,
below.
A˚strand test
Four studies evaluated the reliability, concurrent validity and
dropout rates of the A˚strand test, the modiﬁed A˚strand test or the
Lean body mass-based A˚strand test. Based on 19 participants,
Hodselmans et al reported the test-retest reliability of the Lean
body mass-based A˚strand test as an ICC of 0.91 (95% CI 0.76 to
0.97), which changed to 0.96 (95% CI 0.91 to 0.99) when one outlier
was excluded.30 The limits of agreement for the Lean body mass-
based A˚strand test were 32.0 and 32.8% including the outlier, and
13.8 and 16.9% excluding the outlier. Assessing the conventional
A˚strand test in 31 participants, Keller et al showed a test-retest
reliability ICC of 0.96 and a critical difference of 21%.32 Based on
these studies, test-retest reliability seems to be excellent.
Smeets and van Soest evaluated the concurrent validity of the
A˚strand test with a modiﬁed A˚strand test in 31 participants with
musculoskeletal pain disorder.35 They reported an intraclass
coefﬁcient of 0.79 between the two tests. The limits of agreement
for VO2max were 15.9% from the mean difference, which equated
to 8.5 ml/kg of lean body mass per minute in VO2max. Viitanen
evaluated the concurrent validity of the A˚strand test with a
modiﬁed A˚strand test and a 2-km walk test in 69 participants.39
The ICC was 0.20 (95% CI –0.29 to 0.50) at entry of the study and
0.47 (95% CI 0.15 to 0.67) after 3 months. In addition, Spearman’s
rank correlation between these two tests was low: r = 0.37
(p < 0.01) at entry and r = 0.34 (p < 0.01) after 3 months. These
tests showed low and non-signiﬁcant correlations with the visual
analog scale for pain, with r-values ranging from 0.11 to –0.19 for
the A˚strand test and 0.09 to –0.22 for the 2-km walk test.
Smeets and van Soest described a slight underestimation of
VO2max with the modiﬁed A˚strand test,
35 with VO2max outcomes
an average of 9.96% higherwhen the conventional A˚strand testwas
used (95% CI 6.4 to 13.5%) in the pain group. The dropout rates of
the A˚strand test and the modiﬁed A˚strand test were moderate at 5
to 16%.30,35 The 2-kmwalk test was not recommended for subjects
with chronic pain syndrome, for example ﬁbromyalgia, due to
underestimation of exercise capacity.38
Submaximal bicycle ergometer aerobic capacity test not following
A˚strand protocol
Three of the 14 studies assessed reliability (test-retest
reliability) and acceptability (dropout rate) of other submaximal
bicycle ergometer tests. Protocols of these exercise tests are
available from the authors. Test-retest reliability was good in the
Table 1
Summary of included studies (n=14).
Study
Design
Participants Exercise tests Results Quality
Smeets35
Cross-over
randomised
trial
n =31
Musculoskeletal pain
disorders
Age=48 yr (SD 8)
A˚strand test and modiﬁed
A˚strand test, repeated at 7 d
Validity: ICC=0.79, against 33 healthy matched
controls.
Critical difference: On B-A plots, the limits of
agreement =15.9% (8.5 ml/kg LBM min1). Slight
underestimation of VO2max with the modiﬁed test
by 9.96% (95% CI 6.4 to 13.5).
Dropout rate: A˚strand test =5/31 (16%), modiﬁed
A˚strand test: 5/31 (16%).
Usability: modiﬁed A˚strand=acceptable
Reliability: fair
Criterion validity: fair
Hodselmans30
Observational
study
n=20
Non-speciﬁc chronic LBP
with median duration of 68
mth (range 8 to 180)
Age=34 yr (SD 9)
LBM-based A˚strand test,
repeated at 2 wk
Maximal bicycle test, once for
validity
Test-retest reliability: ICC=0.91 (95% CI 0.76 to 0.97),
or excluding outlier 0.96 (95% CI 0.91 to 0.99).
Validity: ICC=0.94 (95% CI 0.85 to 0.98), or excluding
outlier 0.98 (955 CI 0.95 to 0.99).
Critical difference: On B-A plots, limits of
agreement =32.0 to 32.8%, or excluding outlier 13.8
to 16.9%.
Dropout rate: 1/20 (5%)
Reliability: poor
Viitanen38
Non-randomised
intervention
study
n=69
Fibromyalgia
Age=48 yr (SD 7)
A˚strand test and 2-km walk
test, repeated at 2 mth
Validity: ICC=0.20 (95% CI –0.29 to 0.50) at baseline,
0.47 (95% CI 0.15 to 0.67) at 3 mth.
Correlation between tests: r=0.37 (p<0.01) at
baseline, r=0.34 (p<0.01) at 3 mth.
Reliability: alpha coefﬁcients =0.54 at baseline, 0.47
at 3 mth.
Kendal-T coefﬁcients 0.32 and 0.41 for ordinal
correlation of the tests.
Criterion validity: Results did not correlate with pain
VAS, Spearman’s r=–0.19 to 0.11 for A˚strand test,
–0.22 to 0.09 for 2-km walk.
Usability: 2-km walk test not recommended for
subjects with chronic pain syndrome, eg,
ﬁbromyalgia.
Reliability: fair
Criterion validity: poor
Keller32
Observational
study
n=31
LBP
Age=34 yr (range 29 to 43)
A˚strand bicycle test, repeated
twice at 5–10 d intervals
Test-retest reliability: ICC=0.96.
Critical difference: On B-A plots, limits of
agreement =21% for LBP.
Reliability: fair
Protas41
Non-randomised
intervention
study
n=683
Chronic work-related spinal
disorders
Age=41 yr (SD 9) (cervical);
40 yr (SD 10) (lumbar)
Submaximal bicycle test,
assessed before and after
rehabilitation
Dropout rate before rehabilitation: 20/179 (11%)
cervical, 165/504 (33%) lumbar.
Dropout rate after rehabilitation: 0/683 (0%).
Unclear
van Santen40
Randomised
trial
n =37
Fibromyalgia
Age=42 yr (range 20 to 58)
Bicycle test, repeated at 7 d Reliability: ICC=0.86. Reliability: fair
van Santen39
Randomised
trial
n =30
Fibromyalgia
Age=45 yr (range 26 to 60)
Bicycle test, repeated at 5 d Reliability: ICC=0.70. Reliability: fair
Smeets42
Observational
study
n=53
Non-speciﬁc chronic LBP
without task experience
(n=30) or with task
experience (n=23)
Age=43 yr (SD 9)
5-minwalk test, repeated at 5
to 9 d
Test-retest reliability: ICC=0.89 (95% CI 0.81 to 0.93).
Critical difference: On B-A plots, limits of
agreement =20%.
Task experience did not signiﬁcantly inﬂuence test-
retest differences.
Usability: 5-min walk test = acceptable
Reliability: fair
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Table 1 (Continued )
Study
Design
Participants Exercise tests Results Quality
Harding43
Non-randomised
intervention
study
n=147
Chronic pain
Age=50 yr (range 20 to 84)
10-min walk test, measured
using 2 raters, and repeated
at 12 wk
Inter-rater reliability: ICC=0.994 (n=24).
Test-retest reliability: Pearson’s r=0.944 (n=30).
Criterion validity: Spearman’s r=0.985, indicating
strong correlation with 5-min walk test.
Reliability: poor
Criterion validity: fair
Simmonds45
Observational
study
n=44
LBP
Age 43 yr (range 21 to 63)
5-min walk test, repeated at
2 wk
Test-retest reliability: ICC=0.87.
Criterion validity: Pearson’s r=0.617 for correlation
between 5-min walk and 50-ft walk. Correlations
with 7 other physical performance tests were weak.
Usefulness =no specialised equipment required,
acceptable to all subjects.
Reliability: fair
Criterion validity: poor
Sato44
Observational
study
n=82
Chronic pain
Age=82 yr (SD 8)
6-min walk test, repeated at
2 wk
Inter-rater reliability: ICC=1.000.
Intra-rater reliability: ICC=0.979.
Validity: Spearman’s r=0.652, indicating signiﬁcant
association with the Functional Independence
Measure.
Reliability: fair
Criterion validity: poor
Mannerkorpi46
Observational
study
n=69
Women with ﬁbromyalgia
Age=45 yr (SD 8)
6-min walk test Dropout rate: 1/69 (1%).
6-min walk test showed a fair relationship with the
Physical Function domains of the SF-36 and the FIQ,
and a moderate-to-good relationship with the ASES
function scale.
Correlations between the performance-based tests
and the activity limitations tended to be higher than
those between performance and pain.
Criterion validity: fair
Taylor47
Observational
study
Reliability:
n=44
Chronic LBP
Age=48 yr (SD 14)
Shuttle walk test, repeated
within 1 wk
Reliability: ICC=0.99.
Critical difference: On B-A plots, mean
difference =2.5 m, with limits of agreement of 52 m
and –47 m.
Reliability: fair
Responsiveness:
n=111
Age=35 (SD 9), 40 (SD 9)
and 46 (SD 13) yr
Shuttle walk test, repeated at
2 and 25 mth
Responsiveness: Effect size =1.42 for ﬁtness group,
0.23 for control group, and 0.94 for orthopaedic clinic
group.
Usability: simple, quick.
Wittink25
Observational
study
n=63
Chronic LBP
Age=40 yr (SD 8)
Modiﬁed symptom-limited
Bruce-treadmill test
Validity: Spearman’s r=0.43, indicating a strong
correlation with the Physical Function domain of the
SF-36.
Criterion validity: fair
ASES=American Shoulder and Elbow Surgeons, B-A=Bland-Altman, FIQ=Fibromyalgia Impact Questionnaire, ICC= Intraclass correlation coefﬁcient, LBM= lean body mass,
LBP= low back pain, SF-36=Short-Form Health Survey, VO2max=maximal aerobic capacity, Wmax =maximal work capacity.
Ratter et al: Psychometrics of exercise tests in chronic pain patients148studies by van Santen et al, 39,40 with ICCs of 0.70 to 0.86. The
dropout rates of 0 to 33% among the various tests were considered
acceptable.41
Walk tests
Five studies evaluated the reliability, criterion validity and
acceptability of walk tests. Smeets et al42 assessed test-retest
reliability, reporting an ICC of 0.89 (95% CI 0.81 to 0.93). Harding
et al43 reported a Pearson’s r of 0.944. Task experience did not
signiﬁcantly inﬂuence test-retest differences.42 Inter-rater reli-
ability was reported as ICCs of 0.994 by Harding et al43 and 1.000
by Sato et al.44 Intra-rater reliability was reported as an ICC of
0.979 by Sato et al44 and day-to-day reliability as an ICC of 0.87 by
Simmonds et al.45 The critical difference was 20%.42 Therefore,
reliability of the 5-minute, 6-minute or 10-minute walk tests is
good to excellent. The 5-minute walk test is considered useful.42,45
No specialised equipment is required and walk tests appear to be
acceptable for people with chronic low back pain.45
Criterion validity was established between the 5-minute and
10-minute walk tests with a high Spearman’s rank correlation ofr = 0.985.43 Criterion validity of thewalk tests was assessed against
the 50-foot walk, the Functional Independence Measures (FIM)
scale, various performance-based tests, the Short-Form Health
Survey (SF-36), the Fibromyalgia Impact Questionnaire (FIQ), and
the American Shoulder and Elbow Surgeons (ASES) Function
questionnaire. Simmonds et al45 reported a moderate correlation
of the 5-minute walk test with the 50-foot walk, r = 0.617. Sato
et al44 reported a signiﬁcant correlation of the 6-minute walk test
with the Functional Independence Measures scale (r = 0.652,
p < 0.01), which was used to evaluate activities of daily living.
Mannerkorpi et al46 correlated the 6-minute walk test against
various performance-based tests (chair rising test, hand grip
strength, endurance shoulder muscles, abduction, hand to neck,
hand to scapula) but the criterion validity was fair to moderate,
with r-values ranging from –0.46 to 0.63. Criterion validity was
established between the 6-minute walk tests and two subscales of
the Fibromyalgia Impact Questionnaire: the physical function scale
(r = –0.48, p < 0.001) and the pain scale (r = –0.39, p < 0.01). In the
same study,46 the 6-minute walk test also correlated with the
Short-FormHealth Survey (SF-36) physical function scale (r = 0.49,
Research 149p < 0.001), the SF-36 bodily pain scale (r = 0.38, p < 0.01), the
American Shoulder and Elbow Surgeons function scale (r = 0.68,
p < 0.001) and pain scale (r = 0.53, p < 0.001). In summary, the 6-
minute walk test showed a fair relationship with the SF-36
physical function scale and the Fibromyalgia Impact Questionnaire
physical function scale, and a moderate-to-good relationship with
the American Shoulder and Elbow Surgeons function scale.46
Concurrent validity with the performance-based tests and the
other quality of life scales was low to moderate. The performance-
based measures correlated more strongly with activity limitations
than with pain.46 The dropout rate of 1% was low.46
Shuttle walk test
Taylor et al47 reported test-retest reliability with an ICC of 0.99,
a mean difference of 2.5 m, and upper and lower limits of
agreement of –47 and 52 m. They concluded that the shuttle walk
test is a reliable and responsive test and is simple to administer.
Modiﬁed symptom-limited Bruce treadmill test
Wittink et al25 assessed the concurrent validity of the modiﬁed
treadmill test with the SF-36 scale and found a moderate
relationship (Spearman’s r = 0.43) in 63 people with chronic low
back pain.
Discussion
This systematic review identiﬁed 14 eligible studies about
measurement properties of physical capacity tests in people with
chronic pain, ﬁbromyalgia and chronic fatigue disorders. Exhaus-
tive assessment of methodological quality showed some potential
bias due to lack of blinding, doubt over whether the measurement
was independent, and no gold standard. This may have allowed
overestimation of some of the psychometric properties reported.
Although the demographic features and disease severity of the
participants were comparable among the studies, a meta-analysis
could not be performed due to heterogeneity among the study
designs used, heterogeneity of the psychometric properties
evaluated, and incomplete reporting of the data. Therefore,
psychometric data from individual studies were reported quanti-
tatively and qualitatively.
Seven of the 14 studies assessed criterion validity of the
submaximal tests with questionnaires or other submaximal
tests.25,35,38,43–46 Difﬁculties in assessing criterion validity were:
low reproducibility, and operationalisation variability of the
criterion at issue. However, there is no appropriate reference
standard. This could have led to underestimation of the test
validity.
None of the included studies mentioned blinding of outcome
measurement. This should not have an effect on reliability if the test
was done in accordance to the test protocol. However, validity of
the submaximal tests could be overestimated if researchers were
aware of the results of the submaximal tests before assessment of
the questionnaires. This leads to potential for bias in the review.
The stop criteria of the study protocols were comparable: heart
rate too high or too low, signs of serious cardiovascular or
pulmonary difﬁculties, and chest pain. Only one study added
‘fatigue’ as a stop criterion.41 This could have led to a higher
dropout rate at the entry of the study, compared to results of other
studies. It is remarkable, however, that these higher dropout rates
are only presented at the start of the study and not at the end.
Protas et al41 hypothesise that this is based on psychosocial fear-
avoidance associated with pretesting rather than a true indication
of physical deconditioning. Smeets and van Soest35 suggested
strict adherence to the testing protocol and extensive training of
the health care providers to increase the acceptability of the
exercise tests. Practical experiences show that acceptability of
treadmill and bicycle tests is lower in psychosomatic institutions
than in outpatient settings. This is attributed to disease severity
and other demographic features.In four of the 14 studies,38–40,42 assessment of the psychometric
properties of the submaximal tests was not the primary purpose of
the study. Data of measurement properties were sparse and the
methodological shortcomings of the psychometric measurements
could have led to bias.
Five out of 14 studies investigated test batteries of physical
performance tasks.42–46 Submaximal exercise tests such as the 5-
minute, 6-minute or 10-minutewalk tests weremerely one itemof
the test battery. This could have generated an unclear risk of bias
and could cause underestimation or overestimation of the effect
measure because participants had to do the test battery
completely, and not just one exercise test.
Some uncertainties arose about the reliability and criterion
validity of the conventional A˚strand test.27,30,34 Good test-retest
reliability (ICC 0.96) was reported in people with chronic low back
pain32 and moderate concurrent validity with the modiﬁed
A˚strand test (ICC 0.79) in people with musculoskeletal pain
disorders.35 However, the ICC is strongly inﬂuenced by the
variation between subjects32 and the low number of participants
in the included studies, which may have resulted in a spuriously
high estimate of reliability.
Despite good reliability and moderate criterion validity, all the
studies showed low levels of perceived exertion. The low levels of
perceived exertion may be more likely to be due to fear avoidance
than physical deconditioning.
The gold standard for exercise testing is maximal calorimetry,
with detailed assessment of lactate, VO2max, blood pressure and
electrocardiographic data. However, these detailed assessments
are not available to many physiotherapists. Measuring people’s
subjective perception with standardised assessment (such as
rating of perceived exertion), monitoring heart rate, and perform-
ing submaximal exercise tests seem to be the most applicable
methods in daily practice. All of the submaximal exercises
identiﬁed in this review are useful, feasible, and applicable to
the population of interest. At most, one session of 20 to 30 minutes
is necessary for a submaximal test, although a treadmill or a cycle
ergometer are also needed for some of the tests.
Future research in this area should assess the reliability of
submaximal exercise tests with higher quality study designs and
report data in sufﬁcient detail to allow for meta-analysis. Future
studies could also evaluate the concurrent validity of submaximal
exercise tests, compared to maximal tests, in people with chronic
pain, ﬁbromyalgia and chronic fatigue disorders. However, the lack
of studies of maximal testing of people with chronic pain,
ﬁbromyalgia and chronic fatiguedisordersmaybedue todifﬁculties
with such tests.27 Concurrent validity with other physiological
measures, such as heart rate variability could also be investigated.
Heart rate variability is related to emotional arousal48 andmight be
important in the assessment of physical capacity in this population.
In conclusion, there is moderate evidence of the reliability,
validity and acceptability of the evaluated submaximal exercise
tests in people with chronic pain, ﬁbromyalgia and chronic fatigue
disorders. There is no evidence, however, about maximal exercise
tests in this population.What is already known on this topic: Guidelines recom-
mend graded activity in the treatment of chronic pain, fibro-
myalgia and chronic fatigue disorders. Self-reports of physical
disability often do not correlate with pain severity, so objective
assessment of physical capacity is recommended.
What this study adds: Although little is known about maxi-
mal exercise tests in this population,moderate evidence exists
that several submaximal exercise tests are reliable, valid and
acceptable in people with chronic pain, fibromyalgia and
chronic fatigue disorders.eAddenda: Appendices 1 and 2 can be found online at
doi:10.1016/j.jphys.2014.06.011
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